Skip to main content

Nicholas Hoffman & Company, LLC.

SEC CIK
0001678953
Latest filing
Aug 4, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Nicholas Hoffman & Company, LLC., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
11,697
Value
$1.06M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by Nicholas Hoffman & Company, LLC., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202611,697$1.06M<0.1%−2,159−15.6%ReducedHolders
Q1 202613,856$1.42M<0.1%−218−1.5%ReducedHolders
Q4 202514,074$1.76M<0.1%+43+0.3%AddedHolders
Q3 202514,031$1.88M<0.1%−18−0.1%ReducedHolders
Q2 202514,049$1.91M<0.1%+2,546+22.1%AddedHolders
Q1 202511,503$1.53M0.1%+246+2.2%AddedHolders
Q4 202411,257$1.27M0.1%−164−1.4%ReducedHolders
Q3 202411,421$1.30M0.1%+14+0.1%AddedHolders
Q2 202411,407$1.19M0.1%−140−1.2%ReducedHolders
Q1 202411,547$1.31M0.1%−2,240−16.2%ReducedHolders
Q4 202313,787$1.52M0.1%+377+2.8%AddedHolders
Q3 202313,410$1.30M0.1%−140−1.0%ReducedHolders
Q2 202313,550$1.48M0.1%+260+2.0%AddedHolders
Q1 202313,290$1.35M0.1%+236+1.8%AddedHolders
Q4 202213,054$1.43M0.2%+20+0.2%AddedHolders
Q3 202213,034$1.26M0.1%+522+4.2%AddedHolders
Q2 202212,512$1.36M0.1%+433+3.6%AddedHolders
Q1 202212,079$1.43M0.1%+29+0.2%AddedHolders
Q4 202112,050$1.70M0.1%+379+3.2%AddedHolders
Q3 202111,671$1.38M0.2%−15−0.1%ReducedHolders
Q2 202111,686$1.35M0.2%+1,424+13.9%AddedHolders
Q1 202110,262$1.23M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.